Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
44.98
+1.47 (3.38%)
Nov 22, 2024, 4:00 PM EST - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $2.91 billion as of November 22, 2024. Its market cap has increased by 220.91% in one year.
Market Cap
2.91B
Enterprise Value
2.09B
1-Year Change
220.91%
Ranking
Category
Stock Price
$44.98
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $2.91B, an increase of 249.10%. That is a compound annual growth rate of 34.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.85B | 101.95% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | 2.75B | 229.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyne Therapeutics | 3.02B |
| HUTCHMED (China) | 2.97B |
| Amedisys | 2.97B |
| Bausch Health Companies | 2.93B |
| Vericel | 2.92B |
| Surgery Partners | 2.91B |
| Inari Medical | 2.91B |
| SpringWorks Therapeutics | 2.90B |